{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:06:00Z","timestamp":1770836760649,"version":"3.50.1"},"reference-count":144,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Pregnancy in women with associated endocrine conditions is a therapeutic challenge for clinicians. These disorders may be common, such us thyroid disorders and diabetes, or rare, including adrenal and parathyroid disease and pituitary dysfunction. With the development of assisted reproductive techniques, the number of pregnancies with these conditions has increased. It is necessary to recognize symptoms and correct diagnosis for a proper pharmacotherapeutic management in order to avoid adverse side effects both in mother and fetus. This review summarizes the pharmacotherapy of these clinical situations in order to reduce maternal and fetal morbidity.<\/jats:p>","DOI":"10.3390\/ijerph16050781","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T03:01:23Z","timestamp":1551754883000},"page":"781","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Management of Endocrinopathies in Pregnancy: A Review of Current Evidence"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1523-9116","authenticated-orcid":false,"given":"Daniela","family":"Calina","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca Oana","family":"Docea","sequence":"additional","affiliation":[{"name":"Department of Toxicology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirill Sergeyevich","family":"Golokhvast","sequence":"additional","affiliation":[{"name":"Scientific Education Center of Nanotechnology, Far Eastern Federal University, Vladivostok 690950, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros","family":"Sifakis","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Mitera Maternity Hospital, 71110 Heraklion, Crete, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristides","family":"Tsatsakis","sequence":"additional","affiliation":[{"name":"Department of Forensic Sciences and Toxicology, Faculty of Medicine, University of Crete, 71110 Heraklion, Crete, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonis","family":"Makrigiannakis","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical School, University of Crete, 71110 Heraklion, Crete, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nrendo.2012.169","article-title":"Endocrine disorders in pregnancy: Excessive maternal weight increases risk of infant overgrowth","volume":"8","author":"Osorio","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3892\/br.2017.930","article-title":"Human placental growth hormone in normal and abnormal fetal growth","volume":"7","author":"Velegrakis","year":"2017","journal-title":"Biomed. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Oude Rengerink, K., Logtenberg, S., Hooft, L., Bossuyt, P.M., and Mol, B.W. (2015). Pregnant womens\u2019 concerns when invited to a randomized trial: A qualitative case control study. BMC Pregnancy Childbirth, 15.","DOI":"10.1186\/s12884-015-0641-x"},{"key":"ref_4","unstructured":"FDA News Release (2018, November 16). FDA Issues Final Rule on Changes to Pregnancy and Lactation Labeling Information for Prescription Drug and Biological Products, Available online: https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM425398.pdf."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Nelson-Piercy, C. (2015). Handbook of Obstetric Medicine, CRC Press. [5th ed.].","DOI":"10.1201\/b18316"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.beem.2004.03.010","article-title":"Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid","volume":"18","author":"Hershman","year":"2004","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1210\/jcem-65-4-689","article-title":"Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: A mechanism for estrogen-induced elevation of serum TBG concentration","volume":"65","author":"Ain","year":"1987","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4684-5973-9_9","article-title":"Transfer and metabolism of thyroid-related substances in the placenta","volume":"299","author":"Emerson","year":"1991","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1210\/jcem-53-4-813","article-title":"Human cord blood concentrations of thyrotropin, thyroglobulin, and iodothyronines after maternal administration of thyrotropin-releasing hormone","volume":"53","author":"Roti","year":"1981","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12020-013-0086-9","article-title":"Management of hyperthyroidism in pregnancy","volume":"45","author":"Lazarus","year":"2014","journal-title":"Endocrine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9378(03)00944-X","article-title":"Thyrotoxicosis and heart failure that complicate pregnancy","volume":"190","author":"Sheffield","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/aje\/kwt031","article-title":"Neonatal outcomes and birth weight in pregnancies complicated by maternal thyroid disease","volume":"178","author":"Mannisto","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2265.2001.01224.x","article-title":"Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight","volume":"54","author":"Phoojaroenchanachai","year":"2001","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"ref_14","unstructured":"De Groot, L.J., and Jameson, J.L. (2006). Graves\u2019 disease. Endocrinology, Elsevier Saunders. [5th ed.]."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ncpendmet1006","article-title":"A patient with stress-related onset and exacerbations of Graves disease","volume":"5","author":"Vita","year":"2009","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/ajmg.a.32497","article-title":"Choanal atresia associated with maternal hyperthyroidism treated with methimazole: A case-control study","volume":"146A","author":"Barbero","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/thy.2009.0169","article-title":"The Role of Propylthiouracil in the Management of Graves\u2019 Disease in Adults: Report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration","volume":"19","author":"Bahn","year":"2009","journal-title":"Thyroid"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1210\/jc.2011-2803","article-title":"Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society clinical practice guideline","volume":"97","author":"Abalovich","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_19","first-page":"161","article-title":"Timing of Thyroxine Dose Adjustment in Hypothyroid Patients: When are TSH Levels Stable?","volume":"3","author":"Kohler","year":"2014","journal-title":"J. Thyroid Disord. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-102-3-328","article-title":"Propylthiouracil levels in hyperthyroid patients unresponsive to large doses. Evidence of poor patient compliance","volume":"102","author":"Cooper","year":"1985","journal-title":"Ann. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1210\/jcem.86.6.7573","article-title":"The use of antithyroid drugs in pregnancy and lactation","volume":"86","author":"Mandel","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.4158\/EP11339.CR","article-title":"Delayed anithyroid drug-induced agranulocytosis","volume":"18","author":"Mutharasan","year":"2012","journal-title":"Endocr. Pract."},{"key":"ref_23","first-page":"146","article-title":"Inadvertent 131I therapy for hyperthyroidism in the first trimester of pregnancy","volume":"17","author":"Stoffer","year":"1976","journal-title":"J. Nucl. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/thy.2011.0087","article-title":"Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum","volume":"21","author":"Abalovich","year":"2011","journal-title":"Thyroid"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1089\/thy.2012.0205","article-title":"Clinical practice guidelines for hypothyroidism in adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association","volume":"22","author":"Garber","year":"2012","journal-title":"Thyroid"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e19378","DOI":"10.5812\/ijem.19378","article-title":"Thyroid function in pregnancy and its influences on maternal and fetal outcomes","volume":"12","author":"Saki","year":"2014","journal-title":"Int. J. Endocrinol. Metab."},{"key":"ref_27","first-page":"2016","article-title":"Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child","volume":"341","author":"Hollowell","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa040079","article-title":"Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism","volume":"351","author":"Alexander","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1210\/jc.2010-0013","article-title":"Thyroid hormone early adjustment in pregnancy (the THERAPY) trial","volume":"95","author":"Yassa","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/bdra.23051","article-title":"Teratology public affairs committee position paper: Iodine deficiency in pregnancy","volume":"94","author":"Obican","year":"2012","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"851326","DOI":"10.1155\/2013\/851326","article-title":"Screening for maternal thyroid dysfunction in pregnancy: A review of the clinical evidence and current guidelines","volume":"2013","author":"Chang","year":"2013","journal-title":"J. Thyroid Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13224-013-0487-y","article-title":"Prevalence of overt and subclinical thyroid dysfunction among pregnant women and its effect on maternal and fetal outcome","volume":"64","author":"Ajmani","year":"2014","journal-title":"J. Obstet. Gynaecol. India"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-14-1005","article-title":"Management of subclinical hypothyroidism in pregnancy: Are we too simplistic?","volume":"173","author":"Brabant","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1089\/thy.2015.0418","article-title":"Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis","volume":"26","author":"Maraka","year":"2016","journal-title":"Thyroid"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000362597","article-title":"2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children","volume":"3","author":"Lazarus","year":"2014","journal-title":"Eur. Thyroid J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/cen.12605","article-title":"Optimal management of hypothyroidism, hypothyroxinaemia and euthyroid TPO antibody positivity preconception and in pregnancy","volume":"82","author":"Chan","year":"2015","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1210\/jc.2005-1603","article-title":"Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: Effects on obstetrical complications","volume":"91","author":"Negro","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1471-0528.2002.01223.x","article-title":"Transient hyperthyroidism of hyperemesis gravidarum","volume":"109","author":"Tan","year":"2002","journal-title":"BJOG"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"142413","DOI":"10.4061\/2011\/142413","article-title":"Transient non-autoimmune hyperthyroidism of early pregnancy","volume":"2011","author":"Goldman","year":"2011","journal-title":"J. Thyroid Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S2213-8587(13)70086-X","article-title":"Hyperthyroidism in pregnancy","volume":"1","author":"Cooper","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_41","first-page":"140","article-title":"Thyrotoxicosis of Pregnancy","volume":"1","author":"Labadzhyan","year":"2014","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1210\/jc.2012-4233","article-title":"Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort","volume":"98","author":"Mannisto","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1210\/edrv.18.3.0300","article-title":"The regulation of thyroid function in pregnancy: Pathways of endocrine adaptation from physiology to pathology","volume":"18","author":"Glinoer","year":"1997","journal-title":"Endocr. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2265.2001.01353.x","article-title":"Prevalence of gestational thyrotoxicosis in Asian women evaluated in the 8th to 14th weeks of pregnancy: Correlations with total and free beta human chorionic gonadotrophin","volume":"55","author":"Yeo","year":"2001","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"ref_45","unstructured":"Melmed, S., Polonsky, K.S., Larsen, P.R., and Kronenberg, H.M. (2012). William\u2019s Textbook of Endocrinology, Elsevier Saunders."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/jog.12372","article-title":"Clinical analysis of 65 cases of hyperemesis gravidarum with gestational transient thyrotoxicosis","volume":"40","author":"Sun","year":"2014","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1210\/jc.2002-020524","article-title":"Clinical review 152: Postpartum thyroiditis","volume":"87","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12020-015-0698-3","article-title":"Type of fish consumed and thyroid autoimmunity in pregnancy and postpartum","volume":"52","author":"Benvenga","year":"2016","journal-title":"Endocrine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/08916930290031667","article-title":"Postpartum thyroiditis","volume":"35","author":"Lazarus","year":"2002","journal-title":"Autoimmunity"},{"key":"ref_50","first-page":"12","article-title":"Relatively high rate of postpartum thyroiditis in the Straits of Messina area. Predictivity of both postpartum thyroiditis and permanent hypothyroidism by performing, in the first trimester of gestation, thyroid ultrasonography and measurement of serum thyroperoxidase and thyroglobulin autoantibodies","volume":"15","author":"Benvenga","year":"2019","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.4049\/jimmunol.164.11.5545","article-title":"Cutting edge: Persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: Implications in autoimmunity","volume":"164","author":"Lambert","year":"2000","journal-title":"J. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.mcna.2012.01.003","article-title":"Subacute, Silent Thyroiditis, Postpartum","volume":"96","author":"Samuels","year":"2012","journal-title":"Med. Clin. North Am."},{"key":"ref_53","first-page":"305","article-title":"Clinical aspects of recurrent postpartum thyroiditis","volume":"47","author":"Lazarus","year":"1997","journal-title":"Br. J. Gen. Pract."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1530\/eje.0.1390036","article-title":"Prediction of post partum thyroid dysfunction: Can it be improved?","volume":"139","author":"Kuijpens","year":"1998","journal-title":"Eur. J. Endocrinol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1210\/jc.2007-0141","article-title":"Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society Clinical Practice Guideline","volume":"92","author":"Abalovich","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1530\/eje.1.01976","article-title":"The occurrence of permanent thyroid failure in patients with subclinical postpartum thyroiditis","volume":"153","author":"Azizi","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jare.2016.02.007","article-title":"A review on thyroid cancer during pregnancy: Multitasking is required","volume":"7","author":"Khaled","year":"2016","journal-title":"J. Adv. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3892\/mco.2014.472","article-title":"Association of thyroid carcinoma with pregnancy: A meta-analysis","volume":"3","author":"Zhou","year":"2015","journal-title":"Mol. Clin. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1210\/jcem.87.3.8285","article-title":"The effect of pregnancy on thyroid nodule formation","volume":"87","author":"Kung","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_60","first-page":"130","article-title":"Clinical guidelines for management of thyroid nodule and cancer during pregnancy","volume":"61","year":"2014","journal-title":"Endocrinol. Nutr."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1530\/EJE-13-0903","article-title":"Impact of pregnancy on prognosis of differentiated thyroid cancer: Clinical and molecular features","volume":"170","author":"Messuti","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"549609","DOI":"10.4061\/2011\/549609","article-title":"Management of differentiated thyroid cancer in pregnancy","volume":"2011","author":"Imran","year":"2011","journal-title":"J. Thyroid Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0002-9378(85)90434-X","article-title":"Calcium metabolism in pregnancy and the perinatal period: A review","volume":"151","author":"Pitkin","year":"1985","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_64","unstructured":"World Health Organization (2018, November 25). e-Library of Evidence for Nutrition Actions (eLENA). Calcium Supplementation during Pregnancy to Reduce the Risk of Pre-Eclampsia. Available online: https:\/\/www.who.int\/elena\/titles\/calcium_pregnancy\/en."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00404-010-1668-x","article-title":"Recurrent pancreatitis induced by hyperparathyroidism in pregnancy","volume":"284","author":"Krysiak","year":"2011","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/bjs.1800197405","article-title":"Hyperparathyroidism: Generalized osteitis fibrosa with observations upon bones, parathyroid tumors and the normal parathyroid glands","volume":"19","author":"Hunter","year":"1931","journal-title":"Br. J. Surg."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(00)60025-9","article-title":"Tetany in a suckling with latent osteitis fibrosa in the mother","volume":"233","author":"Friderichsen","year":"1939","journal-title":"Lancet"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1753-4887.2012.00491.x","article-title":"Role of calcium during pregnancy: Maternal and fetal needs","volume":"70","author":"Hacker","year":"2012","journal-title":"Nutr. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00404-014-3526-8","article-title":"Primary hyperparathyroidism during pregnancy","volume":"291","author":"Dochez","year":"2014","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2265.2008.03495.x","article-title":"Hyperparathyroidism during pregnancy and the effect of rising calcium on pregnancy loss: A call for earlier intervention","volume":"71","author":"Norman","year":"2009","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9378(42)91117-7","article-title":"The treatment of tetany in pregnancy","volume":"43","author":"Anderson","year":"1942","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1530\/rep.0.1210493","article-title":"Corticotrophin-releasing hormone and human parturition","volume":"121","author":"McLean","year":"2001","journal-title":"Reproduction"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0022-4731(82)90163-7","article-title":"Serum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancy","volume":"16","author":"Foidart","year":"1982","journal-title":"J. Steroid Biochem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/MAJ.0b013e31828aaeee","article-title":"Adrenal diseases during pregnancy: Pathophysiology, diagnosis and management strategies","volume":"347","author":"Kamoun","year":"2014","journal-title":"Am. J. Med. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ecl.2011.09.001","article-title":"Adrenal disorders in pregnancy","volume":"40","author":"Abdelmannan","year":"2011","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0002-9343(80)90178-3","article-title":"Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy","volume":"68","author":"Wilson","year":"1980","journal-title":"Am. J. Med."},{"key":"ref_77","unstructured":"Jameson, J.L., and De Groot, L.J. (2010). Chapter 103: Defects of adrenal steroidogenesis. Endocrinology, Adult and Pediatric, Elsevier Saunders. [6th ed.]."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.steroids.2013.04.007","article-title":"Diagnosis and management of classical congenital adrenal hyperplasia","volume":"78","author":"Marumudi","year":"2013","journal-title":"Steroids"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1210\/jc.2013-1440","article-title":"Approach to the patient: The adult with congenital adrenal hyperplasia","volume":"98","author":"Auchus","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0960-0760(93)90125-G","article-title":"Prenatal diagnosis and treatment of 21-hydroxylase deficiency","volume":"45","author":"Forest","year":"1993","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4158\/2.6.397","article-title":"Management of congenital adrenal hyperplasia during pregnancy","volume":"2","author":"Garner","year":"1996","journal-title":"Endocr. Pract."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/00016348909009909","article-title":"Addison\u2019s disease and pregnancy","volume":"68","author":"Albert","year":"1989","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/BF03347034","article-title":"Diagnosis and management of Addison\u2019s disease during pregnancy","volume":"26","author":"Ambrosi","year":"2003","journal-title":"J. Endocrinol. Invest."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0002-9378(16)38611-2","article-title":"Pregnancy associated with diseases of the adrenal glands","volume":"66","author":"Hunt","year":"1953","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_85","first-page":"752","article-title":"Maternal Addison\u2019s disease and fetal growth retardation. A case report","volume":"29","author":"Hackett","year":"1984","journal-title":"J. Reprod. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1055\/s-2002-36710","article-title":"Corticosteroids and pregnancy","volume":"20","author":"Trainer","year":"2002","journal-title":"Semin. Reprod. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/pgmj.60.703.312","article-title":"Management of endocrine disorders in pregnancy. Part II. Pituitary, ovarian and adrenal disease","volume":"60","author":"Jacobs","year":"1984","journal-title":"Postgrad. Med. J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejogrb.2003.01.001","article-title":"A case of primary Addison\u2019s disease with hyperemesis gravidarum and successful pregnancy","volume":"113","author":"Ozdemir","year":"2004","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF03350272","article-title":"Mineralocorticoids in the management of primary adrenocortical insufficiency","volume":"14","author":"Jadoul","year":"1991","journal-title":"J. Endocrinol. Invest."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/HYPERTENSIONAHA.111.187237","article-title":"Eplerenone use in primary aldosteronism during pregnancy","volume":"59","author":"Cabassi","year":"2012","journal-title":"Hypertension"},{"key":"ref_91","first-page":"83","article-title":"Cushing\u2019s syndrome and pregnancy: Aetiologies and prognosis in twenty-two patients","volume":"1","author":"Guilhaume","year":"1992","journal-title":"Eur. J. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: An Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1210\/jcem-14-1-32","article-title":"Acromegaly and pregnancy","volume":"14","author":"Abelove","year":"1954","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2012.12.015","article-title":"The medical management of Cushing\u2019s syndrome during pregnancy","volume":"168","author":"Lim","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2265.2001.01055.x","article-title":"Recurrent ACTH-independent Cushing\u2019s syndrome in multiple pregnancies and its treatment with metyrapone","volume":"54","author":"Hana","year":"2001","journal-title":"Clin. Endocrinol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3109\/09513590.2010.521268","article-title":"Successful outcome of pregnancy in a patient with Cushing\u2019s disease under treatment with ketoconazole during the first trimester of gestation","volume":"27","author":"Boronat","year":"2011","journal-title":"Gynecol. Endocrinol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0015-0282(16)54828-6","article-title":"Gestational hyperandrogenism","volume":"57","author":"McClamrock","year":"1992","journal-title":"Fertil. Steril."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11906-010-0134-2","article-title":"Prevalence and diagnosis of primary aldosteronism","volume":"12","author":"Rossi","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1080\/01443610701667098","article-title":"Conn\u2019s syndrome in pregnancy successfully treated with amiloride","volume":"27","author":"Steel","year":"2007","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/BF03345503","article-title":"Diagnosis and management of pheochromocytoma during pregnancy","volume":"25","author":"Mannelli","year":"2002","journal-title":"J. Endocrinol. Invest."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/bjs.8976","article-title":"Systematic review of phaeochromocytoma in pregnancy","volume":"100","author":"Biggar","year":"2013","journal-title":"Br. J. Surg."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/HYPERTENSIONAHA.109.147579","article-title":"Pheochromocytoma in pregnancy: A case series and review","volume":"55","author":"Oliva","year":"2010","journal-title":"Hypertension"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4103\/0974-2700.83876","article-title":"Management of paroxysmal hypertension due to incidental pheochromocytoma in pregnancy","volume":"4","author":"Lata","year":"2011","journal-title":"J. Emerg. Trauma Shock"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bpobgyn.2013.08.005","article-title":"Endocrine emergencies in pregnancy","volume":"27","author":"Khoo","year":"2013","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ncl.2018.09.009","article-title":"Pituitary Disorders in Pregnancy","volume":"37","author":"Woodmansee","year":"2019","journal-title":"Neurol. Clin."},{"key":"ref_106","unstructured":"Melmed, S. (2017). Chapter 13: The Pituitary Gland in Pregnancy. The Pituitary, Academic Press. [4th ed.]."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2265.2001.01406.x","article-title":"Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain","volume":"55","author":"Regal","year":"2001","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.beem.2011.05.011","article-title":"Prolactinoma in pregnancy","volume":"25","author":"Molitch","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/EJE-14-0848","article-title":"Endocrinology in pregnancy: Management of the pregnant patient with a prolactinoma","volume":"172","author":"Molitch","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ando.2007.03.008","article-title":"Prolactinoma and estrogens: Pregnancy, contraception and hormonal replacement therapy","volume":"68","author":"Delemer","year":"2007","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ecl.2011.08.007","article-title":"Pituitary disorders during pregnancy","volume":"40","author":"Motivala","year":"2011","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"ref_112","first-page":"337","article-title":"Influence of pregnancies on prolactinomas","volume":"100","author":"Rjosk","year":"1982","journal-title":"Acta Endocrinol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12020-014-0334-7","article-title":"Prolactinomas, cabergoline, and pregnancy","volume":"47","author":"Glezer","year":"2014","journal-title":"Endocrine"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"S267","DOI":"10.4103\/2230-8210.84883","article-title":"Management of prolactinoma with cabergoline treatment in a pregnant woman during her entire pregnancy","volume":"15","author":"Bajwa","year":"2011","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/cen.12370","article-title":"Outcome of prolactinoma after pregnancy and lactation: A study on 73 patients","volume":"80","author":"Domingue","year":"2014","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/oxfordjournals.humrep.a137010","article-title":"Is pregnancy the best treatment for hyperprolactinaemia?","volume":"4","author":"Crosignani","year":"1989","journal-title":"Hum. Reprod."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/A:1022364514971","article-title":"Medical management of pituitary adenomas: The special case of management of the pregnant woman","volume":"5","author":"Bronstein","year":"2002","journal-title":"Pituitary"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0889-8529(05)70062-1","article-title":"Medical therapy for acromegaly","volume":"28","author":"Newman","year":"1999","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2265.2009.03706.x","article-title":"Effects of octreotide exposure during pregnancy in acromegaly","volume":"72","author":"Maffei","year":"2010","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1210\/jc.2007-0997","article-title":"Treatment of acromegaly with pegvisomant during pregnancy: Maternal and fetal effects","volume":"92","author":"Brian","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1258\/om.2009.090027","article-title":"Diabetes insipidus in pregnancy","volume":"2","author":"Hague","year":"2009","journal-title":"Obstet. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","article-title":"Increased cerebrovascular mortality in patients with hypopituitarism","volume":"46","author":"Bulow","year":"1997","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/EJE-09-0923","article-title":"Pregnancy and pituitary disorders","volume":"162","author":"Karaca","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1365-2265.2003.01822.x","article-title":"Maternal hypothyroxinaemia during early pregnancy and subsequent child development: A 3-year follow-up study","volume":"59","author":"Pop","year":"2003","journal-title":"Clin. Endocrinol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1507\/endocrj.K10E-208","article-title":"Successful pregnancy and delivery in a patient with adult GH deficiency: Role of GH replacement therapy","volume":"58","author":"Sakai","year":"2011","journal-title":"Endocr. J."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00006254-199807000-00025","article-title":"DDAVP use during pregnancy: An analysis of its safety for mother and child","volume":"53","author":"Ray","year":"1998","journal-title":"Obstet. Gynecol. Surv."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.fertnstert.2005.02.022","article-title":"Epidemiologic aspects of postpartum pituitary hypofunction (Sheehan\u2019s syndrome)","volume":"84","author":"Zargar","year":"2005","journal-title":"Fertil. Steril."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejogrb.2015.11.028","article-title":"Questioning the role of pituitary oxytocin in parturition: Spontaneous onset of labor in women with panhypopituitarism\u2014A case series","volume":"197","author":"Shinar","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MAJ.0b013e31821e0e91","article-title":"Headache, pituitary lesion and panhypopituitarism in a pregnant woman: Tumor, apoplexy or hypophysitis?","volume":"342","author":"Tonda","year":"2011","journal-title":"Am. J. Med. Sci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3109\/14767058.2013.819333","article-title":"Reset osmostat in pregnancy: A case report","volume":"27","author":"Harris","year":"2014","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1677\/joe.0.1520345","article-title":"Vasopressin and oxytocin levels during normal pregnancy: Effects of chronic dietary sodium restriction","volume":"152","author":"Hart","year":"1997","journal-title":"J. Endocrinol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1677\/joe.0.1320007","article-title":"Osmoregulatory adaptation in pregnancy and its disorders","volume":"132","author":"Monson","year":"1992","journal-title":"J. Endocrinol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4158\/EP09090.RA","article-title":"Diabetes insipidus in pregnancy: Etiology, evaluation, and management","volume":"15","author":"Ananthakrishnan","year":"2009","journal-title":"Endocr. Pract."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11102-007-0006-1","article-title":"Transient gestational diabetes insipidus diagnosed in successive pregnancies: Review of pathophysiology, diagnosis, treatment, and management of delivery","volume":"10","author":"Kalelioglu","year":"2007","journal-title":"Pituitary"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2174\/157488607781668891","article-title":"Desmopressin 30 years in clinical use: A safety review","volume":"2","author":"Stockner","year":"2007","journal-title":"Curr. Drug. Saf."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1210\/en.2014-1385","article-title":"Diabetes insipidus: Celebrating a century of vasopressin therapy","volume":"155","author":"Qureshi","year":"2014","journal-title":"Endocrinology"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1056\/NEJM198704233161707","article-title":"Diabetes insipidus in pregnancy associated with abnormally high circulating vasopressinase activity","volume":"316","author":"Durr","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1210\/jc.2013-2326","article-title":"Clinical review: Treatment of neurohypophyseal diabetes insipidus","volume":"98","author":"Oiso","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.beem.2011.07.006","article-title":"Pregnancy and other pituitary disorders (including GH deficiency)","volume":"25","author":"Karaca","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1530\/eje.0.1320144","article-title":"Diabetes insipidus and use of desmopressin (Minirin) during pregnancy","volume":"132","author":"Kallen","year":"1995","journal-title":"Eur. J. Endocrinol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ando.2011.09.001","article-title":"Treatment of neurogenic diabetes insipidus","volume":"72","author":"Chanson","year":"2011","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1507\/endocrj.50.437","article-title":"Oral DDAVP is a good alternative therapy for patients with central diabetes insipidus: Experience of five-year treatment","volume":"50","author":"Fukuda","year":"2003","journal-title":"Endocr. J."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1210\/jc.2012-3548","article-title":"Acute diabetes insipidus mediated by vasopressinase after placental abruption","volume":"98","author":"Wallia","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_144","first-page":"482","article-title":"Hereditary nephrogenic diabetes insipidus: A major conundrum during labour and delivery","volume":"2","author":"Castillo","year":"2009","journal-title":"NDT Plus"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/16\/5\/781\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:36:06Z","timestamp":1760186166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/16\/5\/781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":144,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["ijerph16050781"],"URL":"https:\/\/doi.org\/10.3390\/ijerph16050781","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,4]]}}}